Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引:1537
作者
Cardoso, F. [1 ]
Kyriakides, S. [2 ]
Ohno, S. [3 ]
Penault-Llorca, F. [4 ,5 ]
Poortmans, P. [6 ,7 ]
Rubio, I. T. [8 ]
Zackrisson, S. [9 ,10 ]
Senkus, E. [11 ]
机构
[1] Champalimaud Fdn, Breast Unit, Champalimaud Clin Ctr, Lisbon, Portugal
[2] Europa Donna Cyprus, Nicosia, Cyprus
[3] Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan
[4] Ctr Jean Perrin, Dept Pathol, Clermont Ferrand, France
[5] IMoST Univ Auvergne, UMR INSERM 1240, F-1240 Clermont Ferrand, France
[6] Inst Curie, Dept Radiat Oncol, Paris, France
[7] PSL Univ, Paris Sci & Lettres, Paris, France
[8] Clin Univ Navarra, Breast Surg Oncol Unit, Madrid, Spain
[9] Lund Univ, Dept Translat Med Diagnost Radiol, Malmo, Sweden
[10] Skane Univ Hosp Malmo, Malmo, Sweden
[11] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland
关键词
early breast cancer; diagnosis; treatment; follow-up; CARCINOMA-IN-SITU; LYMPH-NODE BIOPSY; POSITIVE SENTINEL NODE; INTERNATIONAL EXPERT CONSENSUS; PATHOLOGICAL COMPLETE RESPONSE; NIPPLE-SPARING MASTECTOMY; ADJUVANT SYSTEMIC THERAPY; ONCOLOGY-AMERICAN SOCIETY; INDIVIDUAL PATIENT DATA; BRCA MUTATION CARRIERS;
D O I
10.1093/annonc/mdz173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1194 / 1220
页数:27
相关论文
共 212 条
  • [41] Weight loss in breast cancer patient management
    Chlebowski, RT
    Aiello, E
    McTiernan, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 1128 - 1143
  • [42] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741
    Citron, ML
    Berry, DA
    Cirrincione, C
    Hudis, C
    Winer, EP
    Gradishar, WJ
    Davidson, NE
    Martino, S
    Livingston, R
    Ingle, JN
    Perez, EA
    Carpenter, J
    Hurd, D
    Holland, JF
    Smith, BL
    Sartor, CI
    Leung, EH
    Abrams, J
    Schilsky, RL
    Muss, HB
    Norton, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) : 1431 - 1439
  • [43] Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0
  • [44] Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
    Coleman, R.
    Powles, T.
    Paterson, A.
    Gnant, M.
    Anderson, S.
    Diel, I.
    Gralow, J.
    von Minckwitz, G.
    Moebus, V.
    Bergh, J.
    Pritchard, K. I.
    Bliss, J.
    Cameron, D.
    Evans, V.
    Pan, H.
    Peto, R.
    Bradley, R.
    Gray, R.
    Bartsch, R.
    Dubsky, P.
    Fesl, C.
    Fohler, H.
    Greil, R.
    Jakesz, R.
    Lang, A.
    Luschin-Ebengreuth, G.
    Marth, C.
    Mlineritsch, B.
    Samonigg, H.
    Singer, C. F.
    Steger, G. G.
    Stoeger, H.
    Olivotto, I.
    Ragaz, J.
    Christiansen, P.
    Ejlertsen, B.
    Ewertz, M.
    Jensen, M-B
    Moller, S.
    Mouridsen, H. T.
    Eiermann, W.
    Hilfrich, J.
    Jonat, W.
    Kaufmann, M.
    Kreienberg, R.
    Schumacher, M.
    Blohmer, J. U.
    Costa, S. D.
    Eidtmann, H.
    Gerber, B.
    [J]. LANCET, 2015, 386 (10001) : 1353 - 1361
  • [45] Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
    Coleman, Robert
    Cameron, David
    Dodwell, David
    Bell, Richard
    Wilson, Caroline
    Rathbone, Emma
    Keane, Maccon
    Gil, Miguel
    Burkinshaw, Roger
    Grieve, Robert
    Barrett-Lee, Peter
    Ritchie, Diana
    Liversedge, Victoria
    Hinsley, Samantha
    Marshall, Helen
    [J]. LANCET ONCOLOGY, 2014, 15 (09) : 997 - 1006
  • [46] Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
    Coles, Charlotte E.
    Griffin, Clare L.
    Kirby, Anna M.
    Titley, Jenny
    Agrawal, Rajiv K.
    Alhasso, Abdulla
    Bhattacharya, Indrani S.
    Brunt, Adrian M.
    Ciurlionis, Laura
    Chan, Charlie
    Donovan, Ellen M.
    Emson, Marie A.
    Harnett, Adrian N.
    Haviland, Joanne S.
    Hopwood, Penelope
    Jefford, Monica L.
    Kaggwa, Ronald
    Sawyer, Elinor J.
    Syndikus, Isabel
    Tsang, Yat M.
    Wheatley, Duncan A.
    Wilcox, Maggie
    Yarnold, John R.
    Bliss, Judith M.
    [J]. LANCET, 2017, 390 (10099) : 1048 - 1060
  • [47] 9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER
    Conte, Pier Franco
    Bisagni, Giancarlo
    Frassoldati, Antonio
    Brandes, Alba Ariela
    Anselmi, Elisa
    Giotta, Francesco
    Aieta, Michele
    Gebbia, Vittorio
    Musolino, Antonino
    Garrone, Ornella
    Taverniti, Cristiana
    Cavazzini, Giovanna
    Turletti, Anna
    Rubino, Daniela
    Picardo, Elisa
    Ferro, Antonella
    Piacentini, Federico
    Balduzzi, Sara
    D'Annico, Roberto
    Guarneri, Valentina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement
    Correa, Candace
    Harris, Eleanor E.
    Leonardi, Maria Cristina
    Smith, Benjamin D.
    Taghian, Alphonse G.
    Thompson, Alastair M.
    White, Julia
    Harris, Jay R.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2017, 7 (02) : 73 - 79
  • [49] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
    Cortazar, Patricia
    Zhang, Lijun
    Untch, Michael
    Mehta, Keyur
    Costantino, Joseph P.
    Wolmark, Norman
    Bonnefoi, Herve
    Cameron, David
    Gianni, Luca
    Valagussa, Pinuccia
    Swain, Sandra M.
    Prowell, Tatiana
    Loibl, Sibylle
    Wickerham, D. Lawrence
    Bogaerts, Jan
    Baselga, Jose
    Perou, Charles
    Blumenthal, Gideon
    Blohmer, Jens
    Mamounas, Eleftherios P.
    Bergh, Jonas
    Semiglazov, Vladimir
    Justice, Robert
    Eidtmann, Holger
    Paik, Soonmyung
    Piccart, Martine
    Sridhara, Rajeshwari
    Fasching, Peter A.
    Slaets, Leen
    Tang, Shenghui
    Gerber, Bernd
    Geyer, Charles E., Jr.
    Pazdur, Richard
    Ditsch, Nina
    Rastogi, Priya
    Eiermann, Wolfgang
    von Minckwitz, Gunter
    [J]. LANCET, 2014, 384 (9938) : 164 - 172
  • [50] Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trial
    Crivellari, Diana
    Gray, Kathryn P.
    Dellapasqua, Silvia
    Puglisi, Fabio
    Ribi, Karin
    Price, Karen N.
    Lang, Istvan
    Gianni, Lorenzo
    Spazzapan, Simon
    Pinotti, Graziella
    Luethi, Jean-Marc
    Gelber, Richard D.
    Regan, Meredith M.
    Colleoni, Marco
    Castiglione-Gertsch, Monica
    Maibach, Rudolf
    Rabaglio, Manuela
    Coates, Alan S.
    Goldhirsch, Aron
    [J]. BREAST, 2013, 22 (02) : 130 - 137